Press Releases

NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR) on behalf of Phreesia stockholders. Our investigation concerns whether Phreesia has violated the federal securities laws and/or engaged in other unlawful business practices.

Click here to participate in the action.

On May 30, 2024, Phreesia... (continue reading...)

NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against 2U, Inc. (“2U” or the “Company”) (NASDAQ: TWOU) in the United States District Court for the District of Maryland on behalf of all persons and entities who purchased or otherwise acquired 2U securities between February 9, 2022 and February 12, 2024, both dates inclusive (the “Class... (continue reading...)

NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Teradata Corporation (“Teradata” or the “Company”) (NYSE: TDC) in the United States District Court Southern District of California on behalf of all persons and entities who purchased or otherwise acquired Teradata securities between February 13, 2023 and February 12, 2024, both dates... (continue reading...)

NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Rivian Automotive, Inc. (“Rivian” or the “Company”) (NASDAQ: RIVN) in the United States District Court for the Central District of California on behalf of all persons and entities who purchased or otherwise acquired Rivian securities between March 1, 2023 and February 21,... (continue reading...)

NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against CVS Health Corporation (“CVS” or the “Company”) (NYSE: CVS) on behalf of CVS stockholders. Our investigation concerns whether CVS has violated the federal securities laws and/or engaged in other unlawful business practices.

Click here to participate in the action.

On June 10, 2024, an article was... (continue reading...)